1Keller MB.Past,present,and future directions for defining optimal treatment outcome in depression:remission and beyond.JAMA,2003,289:3152-3160.
2Rush AJ,Trivedi MH,Wisniewski SR,et al.Acute and longerterm outcomes in depressed outpatients requiring one or several treatment steps:a STAR * D report.Am J Psychiatry,2006,163:1905-1917.
3Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA, 2003,289:3152-3160.
4Ogrodniczuka JS,Piperb WE,Joycec AS.Residual symptoms in depressed patients who successfully respond to short-term psychotherapy.J Affect Disord,2004,82:469-473.
5Keitner GI,Ryan CE,Solomon DA.Realistic expectations and a disease management model for dèpressed patients with persistent symptoms.J Clin Psychiatry,2006,67:1412-1421.
6Nierenberg AA,Husain MM,Trivedi MH,et al.Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse:a STAR * D report.Psychol Med,2010,40:41-50.
7Leon AC,Endicott J,Mueller TI,et al.Psychosocial impairment and recurrence of major depression.Compr Psychiatry,2004,45:423-430.
8Airaksinen E,Wahlin A,Larsson M,et al.Cognitive and social functioning in recovery from depression:Results from a population-based three-year follow-up.J Affect Disord,2006,96:107-110.
9Judd LL,Schettler PJ,Solomon DA,et al.Psychosocial disability and work role function compared across the long-term course of bipolar Ⅰ,bipolar Ⅱ and unipolar major depressive disorders.J Affect Disord,2008,108:49-58.
10Kocsis JH,Schatzberg A,Rush AJ,et al.Psychosocial Outcomes Following Long-term,Double-blind Treatment of Chronic Depression With Sertaline vs Placebo.Arch Gen Psychiatry,2002,59:723-728.
